Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

Glow Stack (GHK-Cu + BPC-157 + TB-500)

Glow Stack (GHK-Cu + BPC-157 + TB-500) The Glow stack combines GHK-Cu, BPC-157, and TB-500 for skin rejuvenation, tissue repair, and anti-inflammatory support. This stack is commonly used for beauty and recovery goals. Glow Stack Quick Overview GHK-Cu Collagen

By Recovery & Performance Peptides Editorial Team

Glow Stack (GHK-Cu + BPC-157 + TB-500)

The Glow stack combines GHK-Cu, BPC-157, and TB-500 for skin rejuvenation, tissue repair, and anti-inflammatory support. This stack is commonly used for beauty and recovery goals.

Glow Stack Quick Overview

GHK-Cu

Collagen, skin remodeling

1–2 mg daily SubQ

BPC-157

Local tissue repair

250–500 mcg daily

TB-500

Systemic healing

2–5 mg weekly

What Is the Glow Stack

The Glow stack layers copper peptide (GHK-Cu) with tissue repair peptides BPC-157 and TB-500. GHK-Cu (glycyl-L-histidyl-L-lysine-copper) is a naturally occurring tripeptide studied for collagen synthesis, skin firmness, and wound healing.BPC-157 supports local tissue repair and gut healing. TB-500 is a thymosin beta-4 fragment involved in cell migration and systemic tissue repair.

The stack has been researched in animal and in vitro models for skin rejuvenation, wound healing, and tissue support. Human studies are limited; most protocols are derived from preclinical data and community practice.

How the Stack Works

GHK-Cu

Collagen & elastin — stimulates synthesis and regulates matrix-degrading enzymes

Skin remodeling — supports dermal fibroblast function and wound healing

Anti-inflammatory — modulates oxidative stress and degenerative pathways

BPC-157

Angiogenesis — supports blood vessel formation for nutrient delivery

Tendon repair — may promote collagen synthesis and fibroblast growth

Local effects — works at injection or injury sites

TB-500

Actin regulation — influences cell structure and motility

Cell migration — supports movement of repair cells to injury sites

Systemic — works throughout the body

Together, GHK-Cu, BPC-157, and TB-500 target skin, local tissue, and systemic repair: GHK-Cu for collagen and complexion, BPC-157 for localized healing, TB-500 for broader tissue regeneration.

Benefits

Skin rejuvenation and collagen support

Improved skin firmness and elasticity

Scar and wound remodeling

Reduced inflammation

Support for tendon, ligament, and joint recovery

Typical Protocol

1–6

7–8

Optional maintenance

Cycle 6–8 weeks on, 4 weeks off. See GHK-Cu guide, BPC-157 protocol, and TB-500 protocol for detailed schedules.

Results Timeline

Week 1–2: Early skin texture changes, inflammation reduction

Week 3–4: Improved firmness, tissue recovery

Week 5–8: Collagen remodeling, scar improvement

Individual timelines vary. See GHK-Cu results timeline for more context.

Stack Calculator

Build this stack in the PeptideUniv Planner →

Related Stacks

Wolverine stack

FAQs

The Glow stack combines GHK-Cu, BPC-157, and TB-500 for skin rejuvenation and tissue repair. GHK-Cu supports collagen and skin health; BPC-157 and TB-500 support tendon, ligament, and wound healing. It is commonly used for beauty and recovery goals.

GHK-Cu, BPC-157, and TB-500 have been studied in preclinical and cosmetic models; human safety data for combined use is limited. Use only under professional guidance. Not medical advice.

Many users report early skin texture changes within 1–2 weeks and improved firmness by weeks 3–4. Collagen remodeling and scar improvement may take 5–8 weeks or longer. Individual timelines vary.

Yes. The Glow stack is designed to combine all three peptides. Some suppliers offer pre-combined formulations. Follow your protocol and use sterile technique.

The stack is commonly used for skin rejuvenation, collagen support, scar remodeling, wound healing, and connective tissue recovery. It may also support joints and inflammation reduction. Research is primarily preclinical; individual results vary.

Sources

Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data (PubMed)

The potential of GHK as an anti-aging peptide (PubMed)

Effects of topical copper tripeptide complex on wound healing in an irradiated rat model (PubMed)

Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon (PubMed)

The actin binding site on thymosin beta4 promotes angiogenesis (PubMed)

The regenerative peptide thymosin β4 accelerates the rate of dermal healing (PubMed)

Related tools

Open calculator at PeptideUniv → · Build stacks in the Planner →

Internal linking

Related Peptides

GHK-Cu

BPC-157

TB-500

Related Protocols

BPC-157 protocol

TB-500 protocol

Related Calculators

GHK-Cu dosage calculator

BPC-157 dosage calculator

TB-500 dosage calculator

Related Stacks

For educational and research purposes only. Not medical advice. Consult a licensed healthcare professional for personal guidance.

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

01

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

DOSAGE SOURCE

What is the recommended Wolverine Stack dosing protocol?

Common Wolverine Stack research protocols use BPC-157 at 250–500 mcg and TB-500 at 2–5 mg per administration, typically administered daily or every other day for 4–6 weeks. When the expanded stack includes GHK-Cu and KPV, these are often added at their standard research ranges—GHK-Cu topically or at 1–2 mg and KPV at 200–500 mcg. The Wolverine Stack dosing schedule may be adjusted based on the specific research objectives and target tissue being studied.
STORAGE

Specifications, Handling, and Storage

Before incorporating BPC-157/TB-500 5/5mg peptide combination into a new study, teams typically review specifications such as the amount per vial, nominal purity percentage, and any notes on recommended storage conditions. These details are important because they determine how stock solutions are prepared, how frequently they should be remade, and what type of containers are appropriate for short-term and long-term storage. Many laboratories prefer to log each vial into an inventory system as soon as it arrives. A typical workflow might include assigning an internal inventory number, scanning the barcode on the shipping label, and recording the lot number from the vial label. Doing this at the receiving bench ensures that no vial is ever used without a clear record of its origin. It also makes it easier to rotate stock so that older vials are used first while newer vials remain in deep storage. Storage practices vary between institutions, but most research teams using BPC-157/TB-500 5/5mg peptide combination rely on designated refrigerators or freezers that are reserved for high-value reagents. Temperature logs, access control, and regular maintenance of refrigeration equipment are simple steps that help protect peptide integrity. Clear “research use only” notation further reinforces that the materials are not intended for any type of administration or diagnostic procedure. Supplemental images showcasing multiple vials together are often used in presentations, internal train…
02

Question drills

Open a question for its connected answer.

01What If I Miss Multiple Doses of BPC-157 During the Protocol?+

Missing 2–3 consecutive days of BPC-157 reduces cumulative growth factor signaling but doesn't reset progress. Resume at the standard 250–500mcg daily dose. Do not double-dose to compensate. The peptide's effect is mediated by sustained VEGF upregulation, so consistency matters more than absolute cumulative dose. Missing an entire week mid-protocol (days 20–27, for example) may justify extending the total protocol by 1–2 weeks to maintain therapeutic exposure, but this is clinical judgment, not hard science.

SOURCE / realpeptides.co ↗
02What If Individual Peptide Results Are Inconsistent Across Study Cohorts?+

Verify peptide purity via HPLC before proceeding. Batch-to-batch variation in synthesis quality is the most common cause of inconsistent outcomes in peptide research. Research-grade peptides should carry certificates of analysis showing ≥98% purity with mass spectrometry confirmation of the correct amino acid sequence. Peptides sourced without third-party verification may contain truncated sequences, incorrect folding, or acetate salt contamination that alters bioavailability. Storage conditions during shipping also matter: if peptides were exposed to ambient temperature for more than 48 hours in transit, protein denaturation may have occurred even if the powder looks normal. Our experience working with investigators shows that 70% of 'non-responder' cohorts trace back to compromised peptide quality, not biological variability.

SOURCE / realpeptides.co ↗
03What If Combining BPC-157 and TB-500 Produces No Measurable Difference in Your Model?+

Verify peptide purity first. Unverified or degraded peptides are the most common cause of null results in replication studies. Sequence variation, impurity contamination, or improper storage can render the compound biologically inactive even if it appears visually intact. Second, confirm your dosing falls within published ranges and that allometric scaling was applied correctly if translating from animal models. Third, assess your measurement endpoints. Angiogenesis markers (CD31 immunostaining, VEGF expression) peak at different timepoints than collagen deposition markers (Masson's trichrome, tensile strength testing). If your analysis window is too early or too late relative to the healing phase, you'll miss the effect entirely.

SOURCE / realpeptides.co ↗
04What If I Miss Several Doses During My Protocol?+

Resume at your next scheduled dose without doubling up. BPC-157 has a short half-life and benefits from daily dosing, but missing 2–3 days does not negate prior progress. Tissue repair is cumulative, not all-or-nothing. TB-500's longer half-life makes it more forgiving of missed doses. Consistency matters, but occasional gaps are not catastrophic.

SOURCE / realpeptides.co ↗
03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

What purity level is required for research-grade GHK-Cu, BPC-157, and TB-500?

Research-grade peptides used in preclinical studies should meet or exceed 98% purity by HPLC. This threshold is widely cited in published preclinical peptide research and provides a standard that minimizes the contribution of impurities to observed experimental outcomes.

RESEARCH

Potential Redundancies to Consider in Study Design

Thoughtful research design requires acknowledging where the KLOW Stack components may produce overlapping rather than purely additive effects: BPC-157 and KPV in gut models: Both peptides have demonstrated protective effects in intestinal epithelial systems through different mechanisms. Researchers studying gut biology should design assays capable of distinguishing VEGF/NO-mediated effects (BPC-157) from NF-kB/MCR-mediated effects (KPV) using selective inhibitors or pathway-specific readouts. TB-500 and GHK-Cu in anti-aging models: Both compounds modulate inflammatory cytokines and extracellular matrix activity. Microarray or RNA-seq approaches may be necessary to fully deconvolute individual contributions in transcriptomic studies. These overlaps are not a design weakness — they reflect the biological reality that repair and regeneration are multi-pathway processes. But researchers publishing from KLOW Stack protocols should plan for mechanistic attribution experiments using the standalone peptides (GHK-Cu, BPC-157, TB-500, KPV) alongside the full stack.

05

Product & matchup locker

Linked catalog and comparison files.

Comparison

BPC-157 vs. TB-500: A Head-to-Head Comparison

To truly understand what BPC-157 and TB-500 are used for, it helps to see their characteristics side-by-side. While both are studied for recovery, their approaches are fundamental…

Continue reading

Related articles